191 related articles for article (PubMed ID: 31805982)
1. Data quality of drug-resistant tuberculosis and antiretroviral therapy electronic registers in South Africa.
Jamieson L; Evans D; Berhanu R; Ismail N; Aucock S; Wallengren K; Long L
BMC Public Health; 2019 Dec; 19(1):1638. PubMed ID: 31805982
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
[TBL] [Abstract][Full Text] [Related]
3. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register.
Schnippel K; Shearer K; Evans D; Berhanu R; Dlamini S; Ndjeka N
Int J Infect Dis; 2015 Oct; 39():89-94. PubMed ID: 26358856
[TBL] [Abstract][Full Text] [Related]
4. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
5. Retrospective record review of pregnant women treated for rifampicin-resistant tuberculosis in South Africa.
Walt MV; Masuku S; Botha S; Nkwenika T; Keddy KH
PLoS One; 2020; 15(9):e0239018. PubMed ID: 32970722
[TBL] [Abstract][Full Text] [Related]
6. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
Nglazi MD; Bekker LG; Wood R; Kaplan R
BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
[TBL] [Abstract][Full Text] [Related]
7. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
[TBL] [Abstract][Full Text] [Related]
8. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
[TBL] [Abstract][Full Text] [Related]
9. Drug-resistant tuberculosis among HIV-infected patients starting antiretroviral therapy in Durban, South Africa.
Hom JK; Wang B; Chetty S; Giddy J; Mazibuko M; Allen J; Walensky RP; Losina E; Freedberg KA; Bassett IV
PLoS One; 2012; 7(8):e43281. PubMed ID: 22912845
[TBL] [Abstract][Full Text] [Related]
10. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa.
Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S
BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670
[TBL] [Abstract][Full Text] [Related]
11. Completeness and accuracy of electronic recording of paediatric drug-resistant tuberculosis in Cape Town, South Africa.
Rose PC; Schaaf HS; du Preez K; Seddon JA; Garcia-Prats AJ; Zimri K; Dunbar R; Hesseling AC
Public Health Action; 2013 Sep; 3(3):214-9. PubMed ID: 26393032
[TBL] [Abstract][Full Text] [Related]
12. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
Schnippel K; Firnhaber C; Ndjeka N; Conradie F; Page-Shipp L; Berhanu R; Sinanovic E
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1106-1111. PubMed ID: 28911353
[TBL] [Abstract][Full Text] [Related]
13. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.
van der Walt M; Lancaster J; Shean K
PLoS One; 2016; 11(3):e0144249. PubMed ID: 26950554
[TBL] [Abstract][Full Text] [Related]
15. Programmatic treatment outcomes in HIV-infected and uninfected drug-resistant TB patients in Khayelitsha, South Africa.
Mohr E; Cox V; Wilkinson L; Moyo S; Hughes J; Daniels J; Muller O; Cox H
Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):425-32. PubMed ID: 25979526
[TBL] [Abstract][Full Text] [Related]
16. Assessment of facility-based tuberculosis data quality in an integrated HIV/TB database in three South African districts.
Murphy JP; Kgowedi S; Coetzee L; Maluleke V; Letswalo D; Mongwenyana C; Subrayen P; Charalambous S; Mvusi L; Dlamini S; Martinson N; Moolla A; Miot J; Evans D
PLOS Glob Public Health; 2022; 2(9):e0000312. PubMed ID: 36962485
[TBL] [Abstract][Full Text] [Related]
17. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa.
Sineke T; Evans D; Schnippel K; van Aswegen H; Berhanu R; Musakwa N; Lönnmark E; Long L; Rosen S
Health Qual Life Outcomes; 2019 May; 17(1):94. PubMed ID: 31151398
[TBL] [Abstract][Full Text] [Related]
18. Integration of TB and ART services fails to improve TB treatment outcomes: comparison of ART/TB primary healthcare services in Cape Town, South Africa.
Kaplan R; Caldwell J; Bekker LG; Jennings K; Lombard C; Enarson DA; Wood R; Beyers N
S Afr Med J; 2014 Mar; 104(3):204-9. PubMed ID: 24897825
[TBL] [Abstract][Full Text] [Related]
19. Use of anti-retroviral therapy in tuberculosis patients on second-line anti-TB regimens: a systematic review.
Arentz M; Pavlinac P; Kimerling ME; Horne DJ; Falzon D; Schünemann HJ; Royce S; Dheda K; Walson JL;
PLoS One; 2012; 7(11):e47370. PubMed ID: 23144818
[TBL] [Abstract][Full Text] [Related]
20. Cost per patient of treatment for rifampicin-resistant tuberculosis in a community-based programme in Khayelitsha, South Africa.
Cox H; Ramma L; Wilkinson L; Azevedo V; Sinanovic E
Trop Med Int Health; 2015 Oct; 20(10):1337-45. PubMed ID: 25975868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
